Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results
09 mai 2024 07h30 HE
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results
Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress
09 mai 2024 07h00 HE
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at ATC 2024
Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection
07 mai 2024 07h05 HE
|
Eledon Pharmaceuticals, Inc.
Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection
Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement
07 mai 2024 07h00 HE
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement
Global Regenerative Medicine Industry Research 2023-2028: Market Driven by Wide Scope in New Therapeutic Areas and Collaborations and Partnerships
03 avr. 2024 09h43 HE
|
Research and Markets
Dublin, April 03, 2024 (GLOBE NEWSWIRE) -- The "Global Regenerative Medicine Market by Product (Stem Cell [Autologous, Allogenic], Immunotherapy, Gene Therapy, Tissue Engineering), Application...
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results
28 mars 2024 16h01 HE
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results
Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection
25 mars 2024 16h56 HE
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection
Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human
21 mars 2024 10h31 HE
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human
Asia-Pacific Organ Transplant Diagnostics Market Forecast to Reach $3.45 Billion by 2033 - Advancements in Human Leukocyte Antigen (HLA) Typing Tests Present Opportunities
08 mars 2024 09h37 HE
|
Research and Markets
Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific Organ Transplant Diagnostics Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.In...
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13 févr. 2024 19h01 HE
|
Eledon Pharmaceuticals, Inc.
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)